A space for lifesaving, collaborative work From left to right: J. Larry Jameson, Liz Magill, Drew Weissman, Katalin Karikó, Gov. Josh Shapiro, Kevin B. Mahoney, Jonathan A. Epstein, and James Hoxie.nocred A space for lifesaving, collaborative work Gov. Josh Shapiro, President Liz Magill, and others from the University community celebrated the new home of the Penn Institute for RNA Innovation.
‘A booster for all of us’ Katalin Karikó and Drew Weissman were named winners of the 2023 Nobel Prize in Physiology or Medicine on Monday, Oct. 2. The Penn Medicine community came together to celebrate the duo.nocred ‘A booster for all of us’ The Penn Medicine community gathered Monday afternoon, toasting to Penn’s new Nobel laureates.
A wrong number, a cryptic message, and a big Nobel win nocred A wrong number, a cryptic message, and a big Nobel win Nobel Prize winners Katalin Karikó and Drew Weissman share their thoughts on their newly minted honor at a University press conference.
Katalin Karikó and Drew Weissman, Penn’s historic mRNA vaccine research team, win 2023 Nobel Prize in Medicine Katalin Karikó and Drew Weissman are the recipients of the 2023 Nobel Prize in Medicine. nocred Katalin Karikó and Drew Weissman, Penn’s historic mRNA vaccine research team, win 2023 Nobel Prize in Medicine The highest honor was bestowed for foundational discoveries that gave the world a vaccine to fight the COVID-19 pandemic.
Can the COVID playbook help end malaria? A Sept. 12 Perry World House event, Can the COVID Playbook Help End Malaria?, looked at the historic fight against this disease, along with new developments in mRNA vaccine technologies and lessons learned from the global COVID-19 pandemic. (Image: Gabby Szczepanek) Can the COVID playbook help end malaria? In a Perry World House conversation, Matthew Laurens, Martina Mchenga, and Drew Weissman discussed how lessons from a global pandemic could help in the fight to eradicate malaria.
SCALAR: A microchip designed to transform the production of mRNA therapeutics and vaccines Led by Michael Mitchell and David Issadore of the School of Engineering and Applied Science, a team of researchers has developed a platform that could rapidly accelerate the development of mRNA-based lipid nanoparticle vaccines and therapeutics at both the small and large scale, SCALAR. (Image: iStock / Anatoly Morozov) SCALAR: A microchip designed to transform the production of mRNA therapeutics and vaccines Researchers have developed a platform that could rapidly accelerate the development of mRNA-based lipid nanoparticle vaccines and therapeutics at both the small and largescale, SCALAR.
Long-awaited accolades for mRNA scientists Katalin Karikó and Drew Weissman (Image: Alex Gardner) Long-awaited accolades for mRNA scientists Katalin Karikó and Drew Weissman Katalin Karikó and Drew Weissman’s key mRNA discoveries more than 15 years earlier made COVID vaccines possible. Now the global public has opportunities to honor them.
‘In vivo’ RNA-based gene editing model for blood disorders developed Image: iStock/Ozgu Arslan ‘In vivo’ RNA-based gene editing model for blood disorders developed Researchers from Penn Medicine and The Children’s Hospital of Philadelphia show that gene editing tools can be delivered via lipid nanoparticles, which would reduce cost and increase access to cutting-edge gene therapies.
People with a conspiracy mindset resist childhood vaccination Image: iStock/Anna Rozhkova People with a conspiracy mindset resist childhood vaccination Research by Dan Romer and Kathleen Hall Jamieson of the Annenberg Public Policy Center explains the role that having a conspiracy mindset plays in adult reluctance to vaccinate children.
Putting biomedical research advances within reach Image: Courtesy of Penn Medicine Magazine Putting biomedical research advances within reach Treatments and vaccines are only useful in the hands of the people who need them, and Penn Medicine is working toward better access and equity for biomedical innovations.